Fuller & Thaler Asset Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,605
Closed -$498K 508
2025
Q4
$498K Sell
46,605
-1,550
-3% -$17K ﹤0.01% 439
2025
Q3
$600K Buy
48,155
+35
+0.1% +$359 ﹤0.01% 416
2025
Q2
$491K Sell
48,120
-13,010
-21% -$115K ﹤0.01% 429
2025
Q1
$483K Sell
61,130
-6,800
-10% -$83.7K ﹤0.01% 446
2024
Q4
$533K Buy
+67,930
New +$341K ﹤0.01% 458
2021
Q4
Sell
-138,183
Closed -$13.3M 540
2021
Q3
$13.3M Sell
138,183
-5,695
-4% -$622K 0.09% 200
2021
Q2
$15.4M Sell
143,878
-4,819
-3% -$474K 0.1% 179
2021
Q1
$13.3M Buy
148,697
+2,859
+2% +$315K 0.09% 194
2020
Q4
$14.7M Buy
+145,838
New +$10.9M 0.14% 154

Other funds holding CRNC

Fuller & Thaler Asset Management's CRNC Position: Q1 2026 in Review

Fuller & Thaler Asset Management sold out of Cerence (CRNC) in Q1 2026, closing a stake of 46,605 shares — an estimated $498K sold.

Fuller & Thaler Asset Management first reported a position in CRNC in Q4 2020 and held it in 9 quarters. The position peaked at $15.4M in Q2 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Fuller & Thaler Asset Management reported no remaining Cerence position as of Q1 2026 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 46,605 Cerence shares in Q1 2026, an estimated $498K.
  • Fuller & Thaler Asset Management first reported a position in Cerence in Q4 2020 and held it in 9 quarters.
  • Fuller & Thaler Asset Management's Cerence position peaked at $15.4M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.